HIV-1 Tat-mediated activation of glycogen synthase kinase-3β contributes to Tat-mediated neurotoxicity

Journal of Neurochemistry

Volumn 73, Issue 2, 1999, Pages 578-586

  Maggirwar, Sanjay B ^a   Tong, Ning ^a   Ramirez, Servio ^a   Gelbard, Harris A ^a   Dewhurst, Stephen ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Glycogen synthase kinase 3 ; Human immunodeficiency virus type 1; Neurotoxicity; Platelet activating factor.; Tat

Indexed keywords

APAFANT; CASEIN KINASE; GLUTATHIONE TRANSFERASE; INOSITOL; LITHIUM CHLORIDE; N METHYL DEXTRO ASPARTIC ACID; NEUROTOXIN; RECOMBINANT PROTEIN; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; GRANULE CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NEUROTOXICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTIMANIC AGENTS; AZEPINES; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELLS, CULTURED; CEREBELLUM; ENZYME ACTIVATION; EXCITATORY AMINO ACID AGONISTS; GENE PRODUCTS, TAT; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASES; HIV-1; LITHIUM CHLORIDE; N-METHYLASPARTATE; NEURONS; NEUROTOXINS; PLATELET ACTIVATING FACTOR; PLATELET AGGREGATION INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; TRIAZOLES;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0032798589     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0730578.x     Document Type: Article

References (44)

1. Adle-Biassett H., Levy Y., Colombel M., Poron F., Natchev S., Keohane C., and Gray F. (1995) Neuronal apoptosis in HIV infection in adults. Neuropathol. Appl. Neurobiol. 21, 218-227.
2. Chen G., Huang L.-D., Jiang Y.-M., and Manji H. K. (1999) The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3. J. Neurochem. 72, 1327-1330.
3. Cross D. A., Alessi D. R., Cohen P., Andjelkovic M., and Hemmings B. A. (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789.
4. Crowder R. J. and Freeman R. S. (1998) Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons. J. Neurosci. 18, 2933-2943.
5. Dudek H., Datta S. R., Franke T. F., Birnbaum M. J., Yao R., Cooper G. M., Segal R. A., Kaplan D. R., and Greenberg M. E. (1997) Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275, 661-665.
6. Everall I. P., Luthert P. J., and Lantos P. L. (1991) Neuronal loss in the frontal cortex in HIV infection. Lancet 337, 1119-1121.
7. Ganju R. K., Munshi N., Nair B. C., Liu Z. Y., Gill P., and Groopman J. E. (1998) Human immunodeficiency virus tat modulates the Flk-1/KDR receptor, mitogen-activated protein kinases, and components of focal adhesion in Kaposi's sarcoma cells. J. Virol. 72, 6131-6137.
8. Gelbard H. A. and Epstein L. G. (1995) HIV-1 encephalopathy in children. Curr. Opin. Pediatr. 7, 655-662.
9. Gelbard H. A., James H. J., Sharer L. R., Perry S. W., Saito Y., Kazee A. M., Blumberg B. M., and Epstein L. G. (1995) Apoptotic neurons in brains from paediatric patients with HIV-1 encephalitis and progressive encephalopathy. Neuropathol. Appl. Neurobiol. 21, 208-217.
10. 133 phosphorylation and activation of CREB transcription factor in both Jurkat lymphoblastoid T cells and primary peripheral blood mononuclear cells. J. Immunol. 160, 3891-3898.
11. Goode N., Hughes K., Woodgett J. R., and Parker P. J. (1992) Differential regulation of glycogen synthase kinase-3β by protein kinase C isotypes. J. Biol. Chem. 267, 16878-16882.
12. + protection of cerebellar granule neurons switched to hondepolarizing medium. Eur. J. Pharmacol. 315, 111-114.
13. He B., Meng Y.-H., and Mivechi N. F. (1998) Glycogen synthase kinase 3β and extracellular signal-regulated kinase inactivate heat shock transcription factor 1 by facilitating the disappearance of transcriptionally active granules after heat shock. Mol. Cell. Biol. 18, 6624-6633.
14. Hedgepeth C. M., Conrad L. J., Zhang J., Huang H. C., Lee V. M., and Klein P. S. (1997) Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Dev. Biol. 185, 82-91.
15. Hong M., Chen D. C., Klein P. S., and Lee V. M. (1997) Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3. J. Biol. Chem. 272, 25326-25332.
16. Jeang K. T. (1998) Tat, Tat-associated kinase, and transcription. J. Biomed. Sci. 5, 24-27.
17. Ketzler S., Weis S., Haug H., and Budka H. (1990) Loss of neurons in the frontal cortex in AIDS brains. Acta Neuropathol. 80, 92-94.
18. Klein P. S. and Melton D. A. (1996) A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. USA 93, 8455-8459.
19. Kumar A., Manna S. K., Dhawan S., and Aggarwal B. B. (1998) HIV-Tat protein activates c-Jun N-terminal kinase and activator protein-1. J. Immunol. 161, 776-781.
20. Lesort M., Jope R. S., and Johnson G. V. W. (1999) Insulin transiently increases tau phosphorylation: involvement of glycogen synthase kinase-3β and Fyn tyrosine kinase. J. Neurochem. 72, 576-584.
21. Li C. J., Ueda Y., Shi B., Borodyansky L., Huang L., Li Y. Z., and Pardee A. B. (1997) Tat protein induces self perpetuating permissivity for productive HIV-1 infection. Proc. Natl. Acad. Sci. USA 94, 8116-8120.
22. Li Y., Hui H., Burgess C. J., Price R. W., Sharp P. M., Hahn B. H., and Shaw G. M. (1992) Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation. J. Virol. 66, 6587-6600.
23. Lovestone S., Hartley C. L., Pearce J., and Anderton B. H. (1996) Phosphorylation of tau by glycogen synthase kinase-3β in intact mammalian cells: the effects on the organization and stability of microtubules. Neuroscience 73, 1145-1157.
24. Lucas F. R. and Salinas P. C. (1997) WNT-7a induces axonal remodeling and increases synapsin I levels in cerebellar neurons. Dev. Biol. 192, 31-44.
25. Magnuson D. S., Knudsen B. E., Geiger J. D., Brownstone R. M., and Nath A. (1995) Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann. Neurol. 37, 373-380.
26. Milani D., Mazzoni M., Borgatti P., Zauli G., Cantley L., and Capitani S. (1996) Extracellular human immunodeficiency virus type-1 Tat protein activates phosphatidylinositol 3-kinase in PC12 neuronal cells. J. Biol. Chem. 271, 22961-22964.
27. Miller T. M., Tansey M. G., Johnson E. M. Jr., and Creedon D. J. (1997) Inhibition of phosphatidylinositol 3-kinase activity blocks depolarization- and insulin-like growth factor I-mediated survival of cerebellar granule cells. J. Biol. Chem. 272, 9847-9853.
28. Nath A., Psooy K., Martin C., Knudsen B., Magnuson D. S., Haughey N., and Geiger J. D. (1996) Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J. Virol. 70, 1475-1480.
29. Neuveut C. and Jeang K. T. (1996) Recombinant human immunodeficiency virus type 1 genomes with tat unconstrained by overlapping reading frames reveal residues in Tat important for replication in tissue culture. J. Virol. 70, 5572-5581.
30. New D. R., Ma M., Epstein L. G., Nath A., and Gelbard H. A. (1997) Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures. J. Neurovirol. 3, 168-173.
31. New D. R., Maggirwar S. B., Epstein L. G., Dewhurst S., and Gelbard H. A. (1998) HIV-1 Tat induces neuronal death via tumor necrosis factor-α and activation of non-N-methyl-D-aspartate receptors by a NFκB-independent mechanism. J. Biol. Chem. 273, 17852-17858.
32. Nonaka S., Katsube N., and Chuang D. M. (1998) Lithium protects rat cerebellar granule cells against apoptosis induced by anticonvulsants, phenytoin and carbamazepine. J. Pharmacol. Exp. Ther. 286, 539-547.
33. Pap M. and Cooper G. M. (1998) Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway. J. Biol. Chem. 273, 19929-19932.
34. Perry S. W., Hamilton J. A., Tjoelker L. W., Dbaibo G., Dzenko K. A., Epstein L. G., Hannun Y., Whittaker J. S., Dewhurst S., and Gelbard H. A. (1998) Platelet-activating factor receptor activation. An initiator step in HIV-1 neuropathogenesis. J. Biol. Chem. 273, 17660-17664.
35. Petito C. K. and Roberts B. (1995) Evidence of apoptotic cell death in HIV encephalitis. Am. J. Pathol. 146, 1121-1130.
36. Philippon V., Vellutini C., Gambarelli D., Harkiss G., Arbuthnott G., Metzger D., Roubin R., and Filippi P. (1994) The basic domain of the lentiviral Tat protein is responsible for damages in mouse brain: involvement of cytokines. Virology 205, 519-529.
37. Sabatier J. M., Vives E., Mabrouk K., Benjouad A., Rochat H., Duval A., Hue B., and Bahraoui E. (1991) Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. J. Virol. 65, 961-967.
38. Sperber B. R., Leight S., Goedert M., and Lee V. M. (1995) Glycogen synthase kinase-3β phosphorylates tau protein at multiple sites in intact cells. Neurosci. Lett. 197, 149-153.
39. Takashima A., Noguchi K., Michel G., Mercken M., Hoshi M., Ishiguro K., and Imahori K. (1996) Exposure of rat hippocampal neurons to amyloid β peptide (25-35) induces the inactivation of phosphatidylinositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3β. Neurosci. Lett. 203, 33-36.
40. Weeks B. S., Lieberman D. M., Johnson B., Roque E., Green M., Loewenstein P., Oldfield E. H., and Kleinman H. K. (1995) Neurotoxicity of the human immunodeficiency virus type 1 tat transactivator to PC12 cells requires the Tat amino acid 49-58 basic domain. J. Neurosci. Res. 42, 34-40.
41. Westendorp M. O., Frank R., Ochsenbauer C., Stricker K., Dhein J., Walczak H., Debatin K. M., and Krammer P. H. (1995) Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375, 497-500.
42. Woodgett J. R. (1994) Regulation and functions of the glycogen synthase kinase-3 subfamily. Semin. Cancer Biol. 5, 269-275.
43. Yao R. and Cooper G. M. (1995) Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 267, 2003-2006.
44. Yost C., Farr G. H. 3rd, Pierce S. B., Ferkey D. M., Chen M. M., and Kimelman D. (1998) GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis. Cell 93, 1031-1041.